732-991-4439 [email protected]

Contact Us

Franzwa Real Estate Advisors LLC

Life Sciences

Life Sciences Practice | Life Sciences | Franzwa Real Estate Advisors LLC

Life Sciences Practice

A large number or our clients are in the Biotechnology and Pharmaceutical fields where we have strong expertise and spend a good amount of time and focus. Our unique specialization is in the facilities requirements of Life Sciences and IT companies including Research & Development, Laboratory, Pilot Plant, cGMP Manufacturing, and Data Center acquisitions and dispositions. We provide a distinct understanding of the nuances that impact the real estate needs of these industries and provide key real estate business advice accordingly. When it comes to incorporating real estate into our clients’ specific corporate strategy, we ensure that their real estate decisions contribute to their bottom line.

We combine obtaining the best value and terms for our clients as we identify the most desirable and appropriate facilities for their particular needs and goals.

Whether you are 1) outgrowing your current space, 2) an International firm setting up Regional US operations, 3) an existing firm relocating or expanding from another state or, 4) simply in need of a consultation to understand your current space allocation needs, we have supported many firms in your position and welcome the opportunity to speak with you about your specific requirements. PLEASE CALL US FOR AN INITIAL COMPLIMENTARY, CONFIDENTIAL CONSULTATION.

The Life Sciences Industry - New Jersey Laboratory And R&D/Manufacturing Trends | Life Sciences | Franzwa Real Estate Advisors LLC

The Life Sciences Industry - New Jersey Laboratory And R&D/Manufacturing Trends

The past 12 months experienced a true upsurge in the sheer volume of biotechnology and pharmaceutical start-ups with Management coming out of NJ companies (most notably Big Pharma) that have merged, downsized or have chosen to leave the State entirely. Typically start-up firms look for small to medium-size blocks of space.

The need for quality, pre-existing laboratory/R&D/manufacturing space is strong but hard to come by. Most often older available spaces remain on the market for lengthy periods of time before being put back to shell condition. Easy access to CROs/CMOs allow these Bio/Pharma companies to delay leasing or building out their facilities until they absolutely have to.

Hiring an experienced and knowledgeable broker as your advocate who understands the buildings/markets/Landlords and construction issues will help you navigate through the details cost effectively and efficiently. PLEASE CALL US FOR A CONSULTATION TO DISCUSS YOUR UNIQUE LIFE SCIENCES FACILITIES REQUIREMENTS.

Big Pharma often contains their laboratory/manufacturing facilities “within their own fenceline”. However, leased or owned facilities outside their corporate fenceline are still often large blocks of space. We are seeing Big Pharma shedding blocks of space (in excess of 50,000sf and often greater than 100,000sf) which is similar to the large single tenant office building scenario. They share the same problems: an inability to cost effectively multi-tenant (or retro-fit) the space to accommodate the needs of smaller users.

The typical lab user in the market today is between 5,000 – 25,000sf. Additionally, there remains an ever present need for incubator space in the 1,000sf – 3,000sf range. This Tenant market is hard pressed to find space available for them.

Here is a quote from one of the largest Laboratory/R&D Landlords in the tri-state area and whose opinion is respected in the Industry: